JGC
IMPL

J. Goldman & Co’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

J. Goldman & Co’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-49,569
Closed -$63K – 394
2023
Q2 		$63K Sell
49,569
-30,650
-38% -$38.9K ﹤0.01% 226
2023
Q1 		$112K Sell
80,219
-120,000
-60% -$168K ﹤0.01% 227
2022
Q4 		$751K Buy
+200,219
New +$751K 0.04% 177